Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS

OBJECTIVE: To monitor the systemic immune responses of patients with multiple sclerosis (MS) under treatment with GNbAC1, a monoclonal antibody against the envelope protein of the MS- associated retrovirus, during a phase 2a trial. METHODS: We analyzed the composition of immune cell subsets and the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neurol Neuroimmunol Neuroinflamm
Main Authors: Zimmermann, Maria, Sanderson, Nicholas S.R., Rasenack, Maria, Lalive, Patrice H., Lang, Alois B., Curtin, Francois, Lindberg, Raija L.P., Kappos, Ludwig, Derfuss, Tobias
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4547879/
https://ncbi.nlm.nih.gov/pubmed/26380353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000144
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki